Saudi Pharm. Ind. & Medical Apps. Corp. - SPIMACO

Activities

Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO) is a leading pharmaceutical manufacturer based in Saudi Arabia. SPIMACO, established in 1986, is a vertically integrated pharmaceutical manufacturer with a significant presence in the Middle East and North Africa (MENA) region. The company is listed on the Saudi Stock Exchange (Tadawul) and is part of the FTSE Saudi Arabia Small Cap Index. SPIMACO operates manufacturing facilities in Saudi Arabia, Egypt, Morocco, and Algeria. Its flagship site in Qassim, Saudi Arabia, spans 150,000 square meters. The company has introduced the region's first Oncology and High Potent Drugs facility, developed in collaboration with AstraZeneca. SPIMACO specializes in producing generic, high-quality pharmaceuticals across more than 60 therapeutic chemical classes. The company's product range includes tablets, capsules, liquids, and semi-solids. SPIMACO also engages in the development, manufacturing, and sales of medical appliances. SPIMACO has established strategic partnerships with global, regional, and local pharmaceutical manufacturers. The company's subsidiaries and joint ventures includes: ARAC Healthcare Company (Saudi Arabia), ARACOM Medical Company (Saudi Arabia), Qassim Medical Services Company (Saudi Arabia), Pharmaceutical Industries Company for Distribution (Saudi Arabia), SPIMACO Saudi Foundation (Algeria), SPIMACO Morocco for Pharmaceutical Industries (Morocco), SPIMACO Misr for Pharmaceutical Industries (Egypt), among others. SPIMACO has a robust distribution network across the GCC and the wider MENA region, supporting solid export growth. The company's mission is to ensure patients' well-being by developing innovative and sustainable solutions. SPIMACO continues to play a pivotal role in the pharmaceutical industry in Saudi Arabia and the broader MENA region, driven by its commitment to quality and innovation.